Role and rationale for the use of milnacipran in the management of fibromyalgia

References

• WolfeFRossKAndersonJRussellIJHebertLThe prevalence and characteristics of fibromyalgia in the general populationArthritis Rheum199538119287818567
   PubMed Web of Science ®Google Scholar
• WhiteKPHarthMClassification, epidemiology, and natural history of fibromyalgiaCurr Pain Headache Rep20015432032911403735
   PubMedGoogle Scholar
• BrancoJCBannwarthBFaildeIPrevalence of fibromyalgia: a survey in five European countriesSemin Arthritis Rheum2009
   Web of Science ®Google Scholar
• MeasePFibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatmentJ Rheumatol200532Suppl 7562115630715
   PubMed Web of Science ®Google Scholar
• BennettRMJonesJTurkDCRussellIJMatallanaLAn internet survey of 2,596 people with fibromyalgiaBMC Musculoskelet Disord200782717349056
   PubMed Web of Science ®Google Scholar
• BennettRMClinical manifestations and diagnosis of fibromyalgiaRheum Dis Clin North Am200935221523219647138
   PubMed Web of Science ®Google Scholar
• AaronLABuchwaldDChronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditionsBest Pract Res Clin Rheumatol200317456357412849712
   PubMed Web of Science ®Google Scholar
• CrooksVAExploring the altered daily geographies and lifeworlds of women living with fibromyalgia syndrome: a mixed-method approachSoc Sci Med200764357758817079063
   PubMed Web of Science ®Google Scholar
• ClauwDJFibromyalgia: update on mechanisms and managementJ Clin Rheumatol200713210210917414543
   PubMed Web of Science ®Google Scholar
• NishishinyaBUrrutiaGWalittBAmitriptyline in the treatment of fibromyalgia: a systematic review of its efficacyRheumatology (Oxford)200847121741174618697829
   PubMed Web of Science ®Google Scholar
• ClauwDJPharmacotherapy for patients with fibromyalgiaJ Clin Psychiatry200869Suppl 2252918537460
   PubMedGoogle Scholar
• MeasePJChoyEHPharmacotherapy of fibromyalgiaRheum Dis Clin North Am200935235937219647148
   PubMed Web of Science ®Google Scholar
• GoldenbergDLBurckhardtCCroffordLManagement of fibromyalgia syndromeJAMA2004292192388239515547167
   PubMed Web of Science ®Google Scholar
• NakagawaAWatanabeNOmoriIMMilnacipran versus other antidepressive agents for depressionCochrane Database Syst Rev20093CD00652919588396
   PubMed Web of Science ®Google Scholar
• MillanMJDescending control of painProg Neurobiol200266635547412034378
   PubMed Web of Science ®Google Scholar
• StahlSMFibromyalgia – pathways and neurotransmittersHum Psychopharmacol200924Suppl 1S11S1719479906
   PubMed Web of Science ®Google Scholar
• AblinKClauwDJFrom fibrositis to functional somatic syndromes to a bell-shaped curve of pain and sensory sensitivity: evolution of a clinical constructRheum Dis Clin North Am200935223325119647139
   PubMed Web of Science ®Google Scholar
• MochizuckiDSerotonin and noradrenaline reuptake inhibitors in animal models of painHum Psychopharmacol200419Suppl 1S151915378668
   PubMed Web of Science ®Google Scholar
• RussellIJVaeroyHJavorsMNybergFCerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritisArthritis Rheum19923555505561374252
   PubMed Web of Science ®Google Scholar
• ArnoldLMKeckPEJrWelgeJAAntidepressant treatment of fibromyalgia. A meta-analysis and reviewPsychosomatics200041210411310749947
   PubMed Web of Science ®Google Scholar
• O’MalleyPGBaldenETomkinsGSantoroJKroenkeKJacksonJLTreatment of fibromyalgia with antidepressants: a meta-analysisJ Gen Intern Med200015965966611029681
   PubMed Web of Science ®Google Scholar
• RaoSGCurrent progress in the pharmacological therapy of fibromyalgiaExpert Opin Investig Drugs2009181014791493
   PubMed Web of Science ®Google Scholar
• CatesMBoggsAAFeldmanJChisholm-BurnsMAWellsBGSchwinghammerTLMalonePMKolesarJMMajor depressive disorderPharmacotherapy Principles and PracticeNew YorkMcGraw-Hill2008569584
   Google Scholar
• AbelesMSolitarBMPillingerMHAbelesAMUpdate on fibromyalgia therapyAm J Med2008121755556118589048
   PubMed Web of Science ®Google Scholar
• MeasePJClauwDJGendreauRMThe efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial [published correction appears in J Rheumatol 2009;36(3):661]J Rheumatol200936239840919132781
   PubMed Web of Science ®Google Scholar
• ClauwDJMeasePPalmerRHGendreauRMWangYMilnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial [published correction appears in Clin Ther 2009;31(2):446]Clin Ther200830111988200419108787
   PubMed Web of Science ®Google Scholar
• PuozzoCPanconiEDeprezDPharmacology and pharmacokinetics of milnacipranInt Clin Psychopharmacol200217Suppl 1S253512369608
   PubMed Web of Science ®Google Scholar
• Forest Laboratories, IncSavella package insert72009 Available from www.savella.comAccessed December 8, 2009
   Google Scholar
• PuozzoCPozetNDeprezDBaillePUngHLZechPPharmacokinetics of milnacipran in renal impairmentEur J Drug Metab Pharmacokinet19982322802869725494
   PubMed Web of Science ®Google Scholar
• PuozzoCAlbinHVinconGDeprezDRaymondJMAmourettiMPharmacokinetics of milnacipran in liver impairmentEur J Drug Metab Pharmacokinet19982322732799725493
   PubMed Web of Science ®Google Scholar
• PuozzoCLensSRehCLack of interaction of milnacipran with the cytochrome p450 isoenzymes frequently involved in the metabolism of antidepressantsClin Pharmacokinet200544997798816122284
   PubMed Web of Science ®Google Scholar
• ParisBLOgilvieBWScheinkoenigJANdikum-MofforFGibsonRParkinsonAIn vitro inhibition and induction of human liver cytochrome p450 enzymes by milnacipranDrug Metab Dispos200937102045205419608694
   PubMed Web of Science ®Google Scholar
• GendreauRMThornMDGendreauJFEfficacy of milnacipran in patients with fibromyalgiaJ Rheumatol200532101975198516206355
   PubMed Web of Science ®Google Scholar
• ArnoldLMGendreauRMSperaAGendreauJWangYMilnacipran 100 mg/day in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial [abstract]Arthritis Rheum200960Suppl 10S527
   Google Scholar
• BrancoJCZachrissonOPerrotSMainguyYon behalf of The Multinational Coordinator Study GroupA European multicenter randomized double-blind placebo-controlled monotheraphy clincal trial of milnacipran in the treatment of fibromyalgiaJ Rheumatol201037485185920156949
   PubMed Web of Science ®Google Scholar
• WolfeFSmytheHAYunusMBThe American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria CommitteeArthritis Rheum19903321601722306288
   PubMed Web of Science ®Google Scholar
• World Health OrganizationObesity: Preventing and Managing the Global EpidemicGeneva, SwitzerlandWorld Health Organization2000 Available from http://whqlibdoc.who.int/trs/WHO_TRS_894.pdfAccessed December 8, 2009
   Google Scholar
• WernerPClauwDJArnoldLMEffect of milnacipran on body weight in patients with fibromyalgia: a pooled analysis of 2 randomized, placebo-controlled trial [poster presentation]Presented at the 24th American Academy of Nurse PractitionersJune 17–21, 2009Nashville, Tennessee
   Google Scholar
• BennettRMScheinJKosinskiMRHewittDJJordanDMRosenthalNRImpact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophenArthritis Rheum200553451952716082646
   PubMed Web of Science ®Google Scholar
• BennettRMBushmakinAGCappelleriJCZlatevaGSadoskyABMinimal clinically important difference in the fibromyalgia impact questionnaireJ Rheumatol20093661304131119369473
   PubMed Web of Science ®Google Scholar
• WareJEJrSF-36 health survey updateSpine (Phila Pa 1976)200025243130313911124729
   PubMed Web of Science ®Google Scholar
• MeasePJClauwDJArnoldLMFibromyalgia syndromeJ Rheumatol200532112270227716265715
   PubMedGoogle Scholar
• MeasePArnoldLMBennettRFibromyalgia syndromeJ Rheumatol20073461415142517552068
   PubMed Web of Science ®Google Scholar
• MeasePArnoldLMChoyEHFibromyalgia syndrome module at OMERACT 9: domain constructJ Rheumatol200936102318232919820221
   PubMed Web of Science ®Google Scholar
• SchwietermanWDIssues in the design of new clinical trials for rheumatoid arthritis therapeuticsNat Clin Pract Rheumatol200841264164819037225
   PubMedGoogle Scholar
• BinghamCO3rdBirdSRSmugarSSXuXTershakovecAMResponder analysis and correlation of outcome measures: pooled results from two identical studies comparing etoricoxib, celecoxib, and placebo in osteoarthritisOsteoarthritis Cartilage200816111289129318514551
   PubMed Web of Science ®Google Scholar
• Ferreira-GonzalezIPermanyer-MiraldaGBusseJWMethodologic discussions for using and interpreting composite endpoints are limited, but still identify major concernsJ Clin Epidemiol200760765165717573977
   PubMed Web of Science ®Google Scholar
• DworkinRHTurkDCWyrwichKWInterpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendationsJ Pain20089210512118055266
   PubMed Web of Science ®Google Scholar
• FarrarJTYoungJPJrLaMoreauxLWerthJLPooleRMClinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scalePain200194214915811690728
   PubMed Web of Science ®Google Scholar
• StrandVSinghJAImproved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trialsAm J Manag Care200814423425418415967
   PubMed Web of Science ®Google Scholar
• US Food and Drug AdministrationDrug Approval Package, Savella (milnacipran HCl tablets) Available from www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022256s000TOC.cfmAccessed December 8, 2009
   Google Scholar
• LittleRJARubinDBStatistical Analysis With Missing Data2nd edHoboken, N.JWiley2002
   Google Scholar
• WilliamsDAGendreauRMClauwDJElectronic diaries have superior discrimination compared to paper-based pain assessment in individuals with fibromyalgia [abstract]Arthritis Rheum200756Suppl 9S607
   Google Scholar
• WilliamsDAGRMClauwDJA comparison between electronic diaries and paper-based pain assessment in individuals with fibromyalgia [abstract]J Pain200894 Suppl 2P16
   Google Scholar
• MeasePPalmerRHWangYHuffordMRDay-to-day pain relief in fibromyalgia patients: results from 2 clinical trials [abstract]Ann Rheum Dis200968Suppl 3692693
   Google Scholar
• GeisserMEClauwDJStrandVGendreauRMPalmerRWilliamsDAContributions of change in clinical status parameters to Patient Global Impression of Change (PGIC) scores among person with fibromyalgia treated with milnacipranPain2010322 [Epub ahead of print]
   Web of Science ®Google Scholar
• GatchelRJTheodoreBREvidence-based outcomes in pain research and clinical practicePain Pract20088645246019000173
   PubMedGoogle Scholar
• HoffmanDLDukesEMThe health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12Int J Clin Pract200862111512618039330
   PubMed Web of Science ®Google Scholar
• ArnoldLMCroffordLJMeasePJPatient perspectives on the impact of fibromyalgiaPatient Educ Couns200873111412018640807
   PubMed Web of Science ®Google Scholar
• SmetsEMGarssenBBonkeBDe HaesJCThe Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigueJ Psychosom Res19953933153257636775
   PubMed Web of Science ®Google Scholar
• HewlettSHehirMKirwanJRMeasuring fatigue in rheumatoid arthritis: a systematic review of scales in useArthritis Rheum200757342943917394228
   PubMed Web of Science ®Google Scholar
• van TubergenACoenenJLandeweRAssessment of fatigue in patients with ankylosing spondylitis: a psychometric analysisArthritis Rheum200247181611932872
   PubMed Web of Science ®Google Scholar
• d’EliaHFRehnbergEKvistGEricssonAKonttinenYMannerkorpiKFatigue and blood pressure in primary Sjogren’s syndromeScand J Rheumatol200837428429218612929
   PubMed Web of Science ®Google Scholar
• ClauwDJPalmerRHHuffordMRZablockiRWangYMilnacipran improves fatigue in patients with fibromyalgia: results from two randomized, double-blind, placebo-controlled trials [poster presentation]Presented at the 72nd Annual American College of Rheumatology and 43rd Annual Association of Rheumatology Health Professionals MeetingSan Francisco, CA2008
   Google Scholar
• GlassJMFibromyalgia and cognitionJ Clin Psychiatry200869Suppl 2202418537459
   PubMed Web of Science ®Google Scholar
• SeidenbergMHaltinerATaylorMAHermannBBWylerADevelopment and validation of a Multiple Ability Self-Report QuestionnaireJ Clin Exp Neuropsychol1994161931048150893
   PubMed Web of Science ®Google Scholar
• ArnoldLMBiology and therapy of fibromyalgia. New therapies in fibromyalgiaArthritis Res Ther20068421216762044
   PubMed Web of Science ®Google Scholar
• GoldenbergDLClauwDJPalmerRHMeasePChenWGendreauRMDurability of therapeutic response to milnacipran treatment for fibromyalgia. Results of a randomized, double-blind, monotherapy 6-month extension studyPain Med201011218019420002596
   PubMed Web of Science ®Google Scholar
• FerreraRPalmerRChenWGendreauRImprovements in fibromyalgia symptoms are sustained for 1 year with milnacipran treatment: results from 2 double-blind, dose-controlled extension studies [abstract]J Pain2009104 Suppl 1S60
   PubMed Web of Science ®Google Scholar
• BrancoJCCherinPSpäthMMainguyYLong-term therapeutic response to milnacipran treatment for fibromyalgia. A European 1-year extension study following a 3-month study [abstract]Arthritis Rheum200960Suppl 10S529
   Google Scholar
• GendreauJPalmerRHThackerKMilnacipran is safe and well tolerated in the treatment of fibromyalgia [poster presentation]Presented at the 27th Annual Scientific Meeting of the American Pain SocietyMay 8–10, 2008Tampa, Florida
   Google Scholar
• PericlouAPalmerRHZhengHLindamoodCEffects of milnacipran on cardiac repolarization in healthy participantsJ Clin Pharmacol201050442243320103694
   PubMed Web of Science ®Google Scholar
• Pfizer IncLyrica package insert42009 Available from www.lyrica.comAccessed December 8, 2009
   Google Scholar
• FergusonJMSSRI antidepressant medications: adverse effects and tolerabilityPrim Care Companion J Clin Psychiatry201031222715014625
   PubMedGoogle Scholar
• RussellIJPerkinsATMichalekJESodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trialArthritis Rheum200960129930919116896
   PubMed Web of Science ®Google Scholar
• RussellIJAlvarez-HorineSZhengYGuintaDRHolmanAJSwickTJEffect of sodium oxybate on pain, PGIc, and composite scores in fibromyalgia – results from a phase 3 controlled trial [abstract]Arthritis Rheum200960Suppl 10S528
   Google Scholar
• GendreauMRClauwDJPalmerRHEfficacy of milnacipran in the treatment of fibromyalgia among patients with varying degrees of depressed mood [poster presentation]Presented at the 161st Annual Meeting of the American Psychiatric AssociationMay 3–8, 2008Washington, DC, USA
   Google Scholar
• BoomershineCSFirst pregabalin and now duloxetine for fibromyalgia syndrome: closer to a brave new world?Nat Clin Pract Rheumatol200841263663718982001
   PubMedGoogle Scholar
• MeasePJSeymourKFibromyalgia: should the treatment paradigm be monotherapy or combination pharmacotherapy?Curr Pain Headache Rep200812639940518973731
   PubMed Web of Science ®Google Scholar
• US National Institutes of Health, Clinical Trials Registry Available from www.clinicaltrials.govAccessed December 8, 2009
   Google Scholar
• BuskilaDSarzi-PuttiniPAblinJNThe genetics of fibromyalgia syndromePharmacogenomics200781677417187510
   PubMed Web of Science ®Google Scholar